Accolade, Inc.

  • Market Cap: Micro Cap
  • Industry: Information Technology Services
  • ISIN: US00437E1029
USD
7.02
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Accolade, Inc. stock-summary
stock-summary
Accolade, Inc.
Information Technology Services
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Health Assistants and clinicians (including nurses, physician medical directors, and behavioral health specialists). It leverages its integrated capabilities, connectivity with providers and the broader healthcare ecosystem, and longitudinal data to engage across the entire member population. The Company’s offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits and Accolade Boost.
Company Coordinates stock-summary
Company Details
660 West Germantown Pike, Suite 500 , PLYMOUTH MEETING PA : 19462
stock-summary
Tel: 1 610 8342989
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 45 Schemes (28.18%)

Foreign Institutions

Held by 87 Foreign Institutions (14.57%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. J. Michael Cline
Chairman of the Board
Mr. Rajeev Singh
Chief Executive Officer, Director
Dr. William Frist
Independent Director
Mr. Jeffrey Jordan
Independent Director
Mr. Peter Klein
Independent Director
Ms. Dawn Lepore
Independent Director
Mr. James Madden
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
105 Million
(Quarterly Results - Nov 2024)
Net Profit:
-121 Million
stock-summary
Industry

Information Technology Services

stock-summary
Market cap

USD 576 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

92.37%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

-26.16%

stock-summary
Price to Book

1.84